`
`http://www. pfizer. com/news/press-release/press-release-detail/pfizer_ co ...
`
`Health Professionals Careers
`
`Investors •
`
`Partners •
`
`News •
`
`En •
`-
`Searc h
`
`About Us•
`
`Products•
`
`Research •
`
`Responsibility •
`
`Health & Well ness •
`
`Contact Us•
`
`News
`
`Press
`Releases
`
`Features
`
`Video Gallery
`
`Frequently
`Requested
`Info
`
`Press Kits &
`Downloads
`
`Social Media
`
`Contact
`Media
`Relations
`
`Home • News & Media » Press Releases » Pfizer Completes Acquisition Of lnnoPharma
`
`Like {I]
`
`8+1 0
`
`Pfizer Completes Acquisition Of InnoPharma
`
`Thursday, September 25, 2014 -8:00am EDT
`Pfizer Inc. (NYSE:PFE) today announced that it has completed its acquisition of the pharmaceutical development company, lnnoPharma, Inc., following receipt
`of United States (U.S.) regulatory approval from ali government authorities required by the agreement and other dosing conditions.
`
`"We believe this acquisition will help Pfizer build a strong sterile injectables pipeline in areas such as oncology and central nervous disorders," said John Young,
`group president, Pfizer Global Established Pharma (GEP). "Sterile injectabies is one of several areas of potential growth for GEP. This acquisition reflects our
`continued view that attractive growth opportunities, both external and organic, exist for the business."
`
`Pfizer Inc.: Working together for a healthier world®
`At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard
`for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as
`well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance
`weilness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier
`innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to
`reliable, affordable health care around the world. For more than 1 SO years, Pfizer has worked to make a difference for ail who rely on us. To learn more, please
`visit us at www.pfizer.com.
`
`PFIZER DISCLOSURE NOTICE
`The information contained in this release is as of September 25, 2014. Pfizer assumes no obligation to update forward-looking statements contained in this
`release as the result of new information or future events or developments.
`
`This release contains forward-looking information about Pfizer's acquisition of lnnoPharma that involves substantial risks and uncertainties. Such risks and
`uncertainties include, among other things, the uncertainties inherent in research and development; decisions by regulatory authorities regarding whether and
`when to approve any applications for lnnoPharma's product candidates, as well as their decisions regarding labeling and other matters that could affect their
`availability or commercial potential; and competitive developments.
`
`A further description of risks and uncertaint ies can be found in Pfizer's Annual Report on Form 1 0-K for the f iscal year ended December 31, 2013 and in its
`subsequent reports on Form 10-Q and Form 8-K.
`
`Contact:
`
`Media:
`Joan Campion, 212-733-2798
`Mobile: 201-761-9384
`Joan.Campion@pfizer.com
`or
`Investor:
`Ryan Crowe, 212-733-8160
`Mobile: 215-260-0914
`Ryan.Crowe@pfizer.com
`
`Career-seekers Health Professionals Change Country
`PAGE 1 OF2
`
`Terms of Use
`
`1 of2
`
`SENJU EXHIBIT 2215
`INNOPHARMA v SENJU
`IPR2015-00903
`4/8/2015 1:28PM
`
`
`
`Pfizer Completes Acquisition Of InnoPharma | Pfizer: One of the world's...
`
`http://www.pfizer.com/news/press-release/press-release-detail/pfizer_co...
`
`Investors
`
`Partners
`
`Contact Us
`
`Privacy Policy
`
`News & Media Business to Business Sltemap
`
`Copyright© 2002-201 5 PFizer Inc. All rights n!served. This information· induding product information· is intended only for n!Sident:s of the Unib!d Stab!s. The products discussed hen!in
`may ha~ different labeling In different countries.
`
`2 of 2
`
`4/8/2015 1:28 PM
`
`PAGE 2 OF 2
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
